Free Trial

Extendicare Inc. (TSE:EXE) to Issue Monthly Dividend of $0.04

Extendicare logo with Medical background

Extendicare Inc. (TSE:EXE - Get Free Report) declared a monthly dividend on Wednesday, April 30th, TickerTech Dividends reports. Investors of record on Thursday, May 15th will be paid a dividend of 0.042 per share on Thursday, May 15th. This represents a $0.50 dividend on an annualized basis and a yield of 3.58%. The ex-dividend date of this dividend is Wednesday, April 30th. This is a 5.0% increase from Extendicare's previous monthly dividend of $0.04.

Extendicare Price Performance

TSE EXE traded up C$0.26 on Thursday, reaching C$14.06. The company's stock had a trading volume of 215,306 shares, compared to its average volume of 188,338. The company has a debt-to-equity ratio of 283.02, a quick ratio of 0.98 and a current ratio of 0.62. Extendicare has a twelve month low of C$7.10 and a twelve month high of C$14.20. The stock has a market cap of C$1.17 billion, a PE ratio of 17.93 and a beta of 1.26. The firm's 50 day moving average is C$12.99 and its two-hundred day moving average is C$11.16.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on EXE shares. Cormark raised shares of Extendicare to a "moderate buy" rating in a research note on Wednesday, February 19th. TD Securities upped their target price on shares of Extendicare from C$10.50 to C$13.00 and gave the company a "hold" rating in a research note on Monday, March 3rd. Finally, BMO Capital Markets increased their price target on shares of Extendicare from C$11.00 to C$13.50 in a research note on Monday, March 3rd.

Get Our Latest Report on Extendicare

Extendicare Company Profile

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.

See Also

Dividend History for Extendicare (TSE:EXE)

Should You Invest $1,000 in Extendicare Right Now?

Before you consider Extendicare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.

While Extendicare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines